Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “administration”

271 pharma patents match "administration" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 271
Index total 30,257
Page 3 / 12

Quick answer

This filtered view shows 271 pharmaceutical patents matching "administration" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

271 results for “administration” · 30,257 patents in full index Clear search

  1. US 11679075

    Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  2. US 11660327

    Methods and compositions for oral administration of proteins

    Oramed Ltd. · Granted May 30, 2023 · Expires May 25, 2043

    granted
  3. US 11660328

    GLP-2 analogs and peptibodies for administration before, during or after surgery

    Takeda Pharmaceutical Company Limited · Granted May 30, 2023 · Expires May 25, 2043

    granted
  4. US 11654142

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  5. US 11590221

    Dengue vaccine unit dose and administration thereof

    Takeda Vaccines, Inc. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  6. US 11564916

    Pharmaceutical composition and administrations thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  7. US 11541070

    Administration of an anti-activin-A compound to a subject

    Atara Biotherapeutics, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  8. US 11529395

    Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF

    Takeda Pharmaceutical Company Limited · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  9. US 11524013

    Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Dec 13, 2022 · Expires Dec 8, 2042

    granted
  10. US 11510916

    Pharmaceutical compositions for intraocular administration and methods for fabricating thereof

    EYE CARE NORTHWEST, PA · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  11. US 11491212

    Subcutaneous administration of modified factor IX polypeptides and treatment of hemophilia B

    Catalyst Biosciences, Inc. · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  12. US 11478502

    Methods and compositions for administration of iron

    American Regent, Inc. · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted
  13. US 11471442

    Administration of gut-selective JAK3 inhibitor

    Theravance Biopharma R&D IP, LLC · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  14. US 11464815

    Dengue vaccine unit dose and administration thereof

    Takeda Vaccines, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  15. US 11439629

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  16. US 11441122

    Regulatory T cell epitopes

    The United States of America, as Represented by the Secretary, Department of Health and Human Services Food and Drug Administration · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  17. US 11439590

    Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof

    PYP CAR NORTHWEST, PA · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  18. US 11439611

    Administration of serine protease inhibitors to the stomach

    The Regents of the University of California · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  19. US 11433091

    Methods and compositions for administration of iron

    American Regent, Inc. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  20. US 11426467

    Dosage regimes for the administration of an anti-CD25 ADC

    ADC THERAPEUTICS SA · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted
  21. US 11406656

    Methods and compositions for administration of iron

    American Regent, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  22. US 11400063

    Early administration of low-dose colchicine after myocardial infarction

    INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  23. US 11389432

    Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent

    Corcept Therapeutics Incorporated · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted
  24. CA 3203431

    PROCEDES D'AMELIORATION DE RENDEMENT MUSCULAIRE OU DE REDUCTION DE FATIGUE CHRONIQUE PAR ADMINISTRATION D'EXOSOMES DERIVES DU LAIT BOVIN

    ABBOTT LAB [US] · Granted Jul 7, 2022 · Expires Jul 2, 2042

    granted